tiprankstipranks
Trending News
More News >
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market
Advertisement

Prime Medicine, Inc. (PRME) Similar Stocks

Compare
803 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Prime Medicine, Inc.
$6.67
$996.12M
95.60%
4 Buy
3 Hold
0 Sell
Moderate Buy
Immatics
$8.73
$1.09B
53.85
-15.65%
4 Buy
0 Hold
0 Sell
Strong Buy
Relay Therapeutics
$5.22
$917.23M
-19.57%
7 Buy
2 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$4.88
$867.49M
141.58%
10 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$3.97
$957.20M
-6.59%
5 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$18.63
$1.00B
-20.49%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRME
Prime Medicine, Inc.
6.67
3.16
90.03%
IMTX
Immatics
8.73
-2.13
-19.61%
RLAY
Relay Therapeutics
5.22
-1.31
-20.06%
TSHA
Taysha Gene Therapies
4.88
2.87
142.79%
SANA
Sana Biotechnology
3.97
-0.26
-6.15%
UPB
Upstream Bio, Inc.
18.59
-4.79
-20.49%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis